{"disease":{"id":"neoplasms-breast","name":"neoplasms breast"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00410475","title":"Cancer Risk in X-Ray Technologists: Second Survey","phase":"","overall_status":"COMPLETED","enrollment_count":146022,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06187350","title":"The Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region Östergötland","phase":"","overall_status":"COMPLETED","enrollment_count":60000,"lead_sponsor_name":"Ostergotland County Council, Sweden","has_results":false},{"nct_id":"NCT00490139","title":"ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":8381,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT00341458","title":"Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics","phase":"","overall_status":"COMPLETED","enrollment_count":6086,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06805812","title":"Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study","phase":"","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT07149636","title":"Health Belief Model-Based Survey on Breast Self-Examination Awareness and Practice Among Community-Dwelling Middle-Aged and Older Women","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT07010939","title":"A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"FangYi","has_results":false},{"nct_id":"NCT06966700","title":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":2400,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT04585074","title":"Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Severance Hospital","has_results":false},{"nct_id":"NCT07581834","title":"Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT04235556","title":"Integrated Care Pathway in Oncology (PASSION)","phase":"","overall_status":"UNKNOWN","enrollment_count":1800,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05797545","title":"Comparison of Ultrasound and Breast MRI for Breast Cancer Detection","phase":"NA","overall_status":"RECRUITING","enrollment_count":1756,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT07500428","title":"Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models","phase":"","overall_status":"RECRUITING","enrollment_count":1380,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06026176","title":"Pattern of Clinical Presentation of Different Breast Disease in Surgical Opd at BPKIHS","phase":"","overall_status":"COMPLETED","enrollment_count":1023,"lead_sponsor_name":"B.P. Koirala Institute of Health Sciences","has_results":false},{"nct_id":"NCT06728527","title":"PARTial BREast RECONstruction With Chest Wall Perforator Flap","phase":"","overall_status":"RECRUITING","enrollment_count":1001,"lead_sponsor_name":"Cambridge University Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT04895709","title":"A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":949,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT05113251","title":"Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":927,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05346224","title":"A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":900,"lead_sponsor_name":"Shanghai Henlius Biotech","has_results":false},{"nct_id":"NCT04141449","title":"A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":874,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03556358","title":"Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":809,"lead_sponsor_name":"Tanvex BioPharma USA, Inc.","has_results":true},{"nct_id":"NCT07505797","title":"ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"iSono Health, Inc.","has_results":false},{"nct_id":"NCT06780176","title":"A Study of Breast Cancer Risk Factors and Outcomes of People in Florida","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT05573893","title":"PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05263362","title":"An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)","phase":"","overall_status":"COMPLETED","enrollment_count":775,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT07214532","title":"Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":725,"lead_sponsor_name":"Natera, Inc.","has_results":false},{"nct_id":"NCT05463276","title":"The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study","phase":"","overall_status":"COMPLETED","enrollment_count":690,"lead_sponsor_name":"Sindh Institute of Urology and Transplantation","has_results":false},{"nct_id":"NCT04108117","title":"Surgical and Oncologic Outcomes After Robotic Nipple Sparing Mastectomy and Immediate Reconstruction","phase":"","overall_status":"COMPLETED","enrollment_count":659,"lead_sponsor_name":"Severance Hospital","has_results":false},{"nct_id":"NCT05007106","title":"MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":613,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06125314","title":"HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation Council","phase":"","overall_status":"COMPLETED","enrollment_count":517,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT01631552","title":"Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":515,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT05172518","title":"Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":512,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07030569","title":"RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT00553358","title":"Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":455,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT00281658","title":"Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":444,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06379880","title":"Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution","phase":"NA","overall_status":"COMPLETED","enrollment_count":411,"lead_sponsor_name":"Centre Paul Strauss","has_results":false},{"nct_id":"NCT05364450","title":"Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors","phase":"NA","overall_status":"COMPLETED","enrollment_count":390,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT06797635","title":"Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":372,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT01160211","title":"A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":369,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05285332","title":"Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":362,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT05430399","title":"Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":349,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04109391","title":"Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":338,"lead_sponsor_name":"Tanvex BioPharma USA, Inc.","has_results":true},{"nct_id":"NCT03762642","title":"Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":335,"lead_sponsor_name":"King Abdulaziz University","has_results":false},{"nct_id":"NCT03500380","title":"A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":301,"lead_sponsor_name":"RemeGen Co., Ltd.","has_results":false},{"nct_id":"NCT01969643","title":"A Safety Study of SGN-LIV1A in Breast Cancer Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"Seagen Inc.","has_results":false},{"nct_id":"NCT03219268","title":"A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":277,"lead_sponsor_name":"MacroGenics","has_results":false},{"nct_id":"NCT03021200","title":"Laser Fluorescence in Cancer Surgical Treatment","phase":"NA","overall_status":"UNKNOWN","enrollment_count":270,"lead_sponsor_name":"Instituto do Cancer do Estado de São Paulo","has_results":false},{"nct_id":"NCT02484404","title":"Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":268,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05194072","title":"A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":250,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT07230535","title":"Evaluation of Wellbeing and Patient Reported Outcomes After Open vs Robotic Mastectomy With DIEP Reconstruction","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Beaumont Hospital","has_results":false},{"nct_id":"NCT04435964","title":"Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment","phase":"","overall_status":"COMPLETED","enrollment_count":247,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}